Download Full Text (524 KB)
• Type 2 diabetes mellitus (T2DM) is a disease commonly presented in the family practice setting. Current therapies include one or multiple medications. Until recently, providers have used algorithms and medical expertise to control T2DM.
• Pharmacogenomics is a branch of pharmacology dealing with genetic variation on a medication response in an individual patient to discover medication compatibility, efficacy or toxicity.
• Analysis of genetic factors are still being discovered; however, this growing field may change the way medications are being prescribed for diabetes. This analysis investigated if pharmacogenetics is a useful tool for prescribing diabetic medications to T2DM patients. It was found that health care providers will be able to maximize therapy to those currently taking diabetic medication.
• The goal would be to personalize the treatment of T2DM by ensuring compatibility of the medication being prescribed. Although many genes have been implicated in the response to diabetic medications, the findings indicate that health care providers can improve the quality of care of patients taking diabetic medications by choosing the correct diabetic medication for the individual patient.
Physician Assistant Studies
Master of Physician Assistant Studies (MPAS)
Diabetes Mellitus, Type 2 -- drug therapy; Diabetes Mellitus, Type 2 -- genetics; Precision Medicine
Endocrinology, Diabetes, and Metabolism | Medical Genetics
VanEmelen, Lucas N., "Does Pharmacogenetics Play a Role in the Treatment of Type II Diabetes Mellitus?" (2015). Physician Assistant Scholarly Project Posters. 108.